Safety of isotreinoin treatment in peanut and soy allergy

Marco Zurlo; Stefano Palazzo; Nada Chaoul; Marcello Albanesi

doi:10.5114/ada.2023.128981

eISSN: 2299-0046
ISSN: 1642-395X

Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii

Current Issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Ethical standards and procedures Reviewers Instructions for authors Publication charge

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

3/2023
vol. 40

Send email

Copy url:

abstract:

Letter to the Editor

Safety of isotreinoin treatment in peanut and soy allergy

Marco Zurlo

^{1, 2}

,

Stefano Palazzo

²

,

Nada Chaoul

^{2, 3}

,

Marcello Albanesi

²

Department of Medicine, Asthma, Allergy and Clinical Immunology Section, University of Verona, Verona, Italy
Marcello Albanesi Allergy and Immunology Unit, Bari, Italy
Department of Interdisciplinary Medicine, Oncology Section, University of Bari, Bari, Italy

Adv Dermatol Allergol 2023; XL (3): 462–463

DOI: https://doi.org/10.5114/ada.2023.128981

Online publish date: 2023/07/16

View full text Get citation

Safety of isotreinoin treatment in peanut and soy allergy

Marco Zurlo 1, 2 , Stefano Palazzo 2 , Nada Chaoul 2, 3 , Marcello Albanesi 2

Marco Zurlo

^{1, 2}

,

Stefano Palazzo

²

,

Nada Chaoul

^{2, 3}

,

Marcello Albanesi

²